Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
Clinical trial NCT05549258 · RECRUITING
Trial details
- NCT number
- NCT05549258
- Sponsor
- Amgen
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-03
- Primary completion
- 2027-04-13
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.